Search

everythinglearnresearchcommunity

for

Search:↓

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Gene differences may affect baldness treatment response in Korean men.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

The enzyme 17β-HSD type 2 mainly performs oxidation in human sebaceous glands, which may help protect against acne.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

Minoxidil may help treat hair loss by reducing the activity of a specific enzyme linked to baldness.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Hair follicles convert androgens, affecting hair loss patterns.

Sebocytes play a key role in controlling androgen levels in human skin.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

IL-24 contributes to skin aging by increasing collagen-degrading enzymes and decreasing collagen production when exposed to air pollution.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Human bone cells mainly produce a type 1 enzyme that may help regulate bone health.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

A new compound shows promise as a topical treatment for hair loss.